CN104383256A - Traditional Chinese medicine composition for treating hemoptysis - Google Patents

Traditional Chinese medicine composition for treating hemoptysis Download PDF

Info

Publication number
CN104383256A
CN104383256A CN201410733093.9A CN201410733093A CN104383256A CN 104383256 A CN104383256 A CN 104383256A CN 201410733093 A CN201410733093 A CN 201410733093A CN 104383256 A CN104383256 A CN 104383256A
Authority
CN
China
Prior art keywords
grams
chinese medicine
radix
medicine composition
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410733093.9A
Other languages
Chinese (zh)
Inventor
唐云峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410733093.9A priority Critical patent/CN104383256A/en
Publication of CN104383256A publication Critical patent/CN104383256A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/342—Adenophora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/40—Cornaceae (Dogwood family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/884—Alismataceae (Water-plantain family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8964—Anemarrhena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8967—Lilium, e.g. tiger lily or Easter lily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968—Ophiopogon (Lilyturf)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating hemoptysis. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicines: 10-20g of radix rehmanniae, 10-20g of Chinese yams, 10-20g of jujube rind, 10-20g of radix adenophorae, 10-20g of lily, 10-20g of radix ophiopogonis, 10-15g of cortex moutan, 10-15g of tuckahoe, 10-15g of rhizoma anemarrhenae, 8-12g of schisandra chinensis, 8-12g of cortex phellodendri, 8-12g of donkey-hide gelatin and 5-10g of rhizoma alismatis. A taking method of the traditional Chinese medicine composition is as follows: all the traditional Chinese medicines are decocted with water to obtain the traditional Chinese medicine composition which is taken once every day to treat hemoptysis according to a certain treatment course. Each traditional Chinese medicine has the pharmacological effect, and balance adjustment on all physical functions can be realized if all the traditional Chinese medicines are simultaneously used, so that the aim of treating hemoptysis can be effectively achieved.

Description

A kind of Chinese medicine composition being used for the treatment of hemoptysis
Technical field
The present invention relates to Chinese medicine composition, especially a kind of Chinese medicine composition being used for the treatment of hemoptysis.
Background technology
The situation of hemoptysis is the very refractory disease of one, and such phenomenon can cause the health of patient to be subject to great injury.The phenomenon of hemoptysis just belongs to a kind of performance clinically.So, on the living conditions, cause the reason of hemoptysis to be many.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of Chinese medicine composition being used for the treatment of hemoptysis, effectively can treat the disease of hemoptysis.
For solving the problems of the technologies described above, technical scheme of the present invention is: a kind of Chinese medicine composition being used for the treatment of hemoptysis, is made up of following Chinese medicine: 10 ~ 20 grams, the Radix Rehmanniae, Rhizoma Dioscoreae 10 ~ 20 grams, Fructus Corni 10 ~ 20 grams, Radix Adenophorae (Radix Glehniae) 10 ~ 20 grams, Bulbus Lilii 10 ~ 20 grams, Radix Ophiopogonis 10 ~ 20 grams, Cortex Moutan 10 ~ 15 grams, 10 ~ 15 grams, Poria, the Rhizoma Anemarrhenae 10 ~ 15 grams, Fructus Schisandrae Chinensis 8 ~ 12 grams, Cortex Phellodendri 8 ~ 12 grams, 8 ~ 12 grams, Colla Corii Asini, Rhizoma Alismatis 5 ~ 10 grams.Instructions of taking of the present invention: with being decocted in water for oral dose, once a day, point course of therapy.The present invention often plants the drug effect that Chinese medicine has self, uses simultaneously and more can carry out balance conditioning to each function of health, effectively can reach the object for the treatment of hemoptysis.
As improvement, described Chinese medicine composition is made up of following Chinese medicine: 10 grams, the Radix Rehmanniae, Rhizoma Dioscoreae 10 grams, Fructus Corni 10 grams, Radix Adenophorae (Radix Glehniae) 10 grams, Bulbus Lilii 10 grams, Radix Ophiopogonis 10 grams, Cortex Moutan 10 grams, 10 grams, Poria, the Rhizoma Anemarrhenae 10 grams, Fructus Schisandrae Chinensis 8 grams, Cortex Phellodendri 8 grams, 8 grams, Colla Corii Asini, Rhizoma Alismatis 5 grams.
As improvement, described Chinese medicine composition is made up of following Chinese medicine: 15 grams, the Radix Rehmanniae, Rhizoma Dioscoreae 15 grams, Fructus Corni 15 grams, Radix Adenophorae (Radix Glehniae) 15 grams, Bulbus Lilii 15 grams, Radix Ophiopogonis 15 grams, Cortex Moutan 12 grams, 12 grams, Poria, the Rhizoma Anemarrhenae 12 grams, Fructus Schisandrae Chinensis 10 grams, Cortex Phellodendri 10 grams, 10 grams, Colla Corii Asini, Rhizoma Alismatis 8 grams.
As improvement, described Chinese medicine composition is made up of following Chinese medicine: 20 grams, the Radix Rehmanniae, Rhizoma Dioscoreae 20 grams, Fructus Corni 20 grams, Radix Adenophorae (Radix Glehniae) 20 grams, Bulbus Lilii 20 grams, Radix Ophiopogonis 20 grams, Cortex Moutan 15 grams, 15 grams, Poria, the Rhizoma Anemarrhenae 15 grams, Fructus Schisandrae Chinensis 12 grams, Cortex Phellodendri 12 grams, 12 grams, Colla Corii Asini, Rhizoma Alismatis 10 grams.
The beneficial effect that the present invention is compared with prior art brought is:
The present invention often plants the drug effect that Chinese medicine has self, uses simultaneously and more can carry out balance conditioning to each function of health, effectively can reach the object for the treatment of hemoptysis.
Detailed description of the invention
Embodiment 1
Be used for the treatment of a Chinese medicine composition for hemoptysis, be made up of following Chinese medicine: 10 grams, the Radix Rehmanniae, Rhizoma Dioscoreae 10 grams, Fructus Corni 10 grams, Radix Adenophorae (Radix Glehniae) 10 grams, Bulbus Lilii 10 grams, Radix Ophiopogonis 10 grams, Cortex Moutan 10 grams, 10 grams, Poria, the Rhizoma Anemarrhenae 10 grams, Fructus Schisandrae Chinensis 8 grams, Cortex Phellodendri 8 grams, 8 grams, Colla Corii Asini, Rhizoma Alismatis 5 grams.Instructions of taking of the present invention: with being decocted in water for oral dose, once a day, point course of therapy.The present invention often plants the drug effect that Chinese medicine has self, uses simultaneously and more can carry out balance conditioning to each function of health, effectively can reach the object for the treatment of hemoptysis.
Embodiment 2
Be used for the treatment of a Chinese medicine composition for hemoptysis, be made up of following Chinese medicine: 15 grams, the Radix Rehmanniae, Rhizoma Dioscoreae 15 grams, Fructus Corni 15 grams, Radix Adenophorae (Radix Glehniae) 15 grams, Bulbus Lilii 15 grams, Radix Ophiopogonis 15 grams, Cortex Moutan 12 grams, 12 grams, Poria, the Rhizoma Anemarrhenae 12 grams, Fructus Schisandrae Chinensis 10 grams, Cortex Phellodendri 10 grams, 10 grams, Colla Corii Asini, Rhizoma Alismatis 8 grams.Instructions of taking of the present invention: with being decocted in water for oral dose, once a day, point course of therapy.The present invention often plants the drug effect that Chinese medicine has self, uses simultaneously and more can carry out balance conditioning to each function of health, effectively can reach the object for the treatment of hemoptysis.
Embodiment 3
Be used for the treatment of a Chinese medicine composition for hemoptysis, be made up of following Chinese medicine: 20 grams, the Radix Rehmanniae, Rhizoma Dioscoreae 20 grams, Fructus Corni 20 grams, Radix Adenophorae (Radix Glehniae) 20 grams, Bulbus Lilii 20 grams, Radix Ophiopogonis 20 grams, Cortex Moutan 15 grams, 15 grams, Poria, the Rhizoma Anemarrhenae 15 grams, Fructus Schisandrae Chinensis 12 grams, Cortex Phellodendri 12 grams, 12 grams, Colla Corii Asini, Rhizoma Alismatis 10 grams.Instructions of taking of the present invention: with being decocted in water for oral dose, once a day, point course of therapy.The present invention often plants the drug effect that Chinese medicine has self, uses simultaneously and more can carry out balance conditioning to each function of health, effectively can reach the object for the treatment of hemoptysis.

Claims (4)

1. be used for the treatment of a Chinese medicine composition for hemoptysis, it is characterized in that: be made up of following Chinese medicine: 10 ~ 20 grams, the Radix Rehmanniae, Rhizoma Dioscoreae 10 ~ 20 grams, Fructus Corni 10 ~ 20 grams, Radix Adenophorae (Radix Glehniae) 10 ~ 20 grams, Bulbus Lilii 10 ~ 20 grams, Radix Ophiopogonis 10 ~ 20 grams, Cortex Moutan 10 ~ 15 grams, 10 ~ 15 grams, Poria, the Rhizoma Anemarrhenae 10 ~ 15 grams, Fructus Schisandrae Chinensis 8 ~ 12 grams, Cortex Phellodendri 8 ~ 12 grams, 8 ~ 12 grams, Colla Corii Asini, Rhizoma Alismatis 5 ~ 10 grams.
2. a kind of Chinese medicine composition being used for the treatment of hemoptysis according to claim 1, is characterized in that: described Chinese medicine composition is made up of following Chinese medicine: 10 grams, the Radix Rehmanniae, Rhizoma Dioscoreae 10 grams, Fructus Corni 10 grams, Radix Adenophorae (Radix Glehniae) 10 grams, Bulbus Lilii 10 grams, Radix Ophiopogonis 10 grams, Cortex Moutan 10 grams, 10 grams, Poria, the Rhizoma Anemarrhenae 10 grams, Fructus Schisandrae Chinensis 8 grams, Cortex Phellodendri 8 grams, 8 grams, Colla Corii Asini, Rhizoma Alismatis 5 grams.
3. a kind of Chinese medicine composition being used for the treatment of hemoptysis according to claim 1, is characterized in that: described Chinese medicine composition is made up of following Chinese medicine: 15 grams, the Radix Rehmanniae, Rhizoma Dioscoreae 15 grams, Fructus Corni 15 grams, Radix Adenophorae (Radix Glehniae) 15 grams, Bulbus Lilii 15 grams, Radix Ophiopogonis 15 grams, Cortex Moutan 12 grams, 12 grams, Poria, the Rhizoma Anemarrhenae 12 grams, Fructus Schisandrae Chinensis 10 grams, Cortex Phellodendri 10 grams, 10 grams, Colla Corii Asini, Rhizoma Alismatis 8 grams.
4. a kind of Chinese medicine composition being used for the treatment of hemoptysis according to claim 1, is characterized in that: described Chinese medicine composition is made up of following Chinese medicine: 20 grams, the Radix Rehmanniae, Rhizoma Dioscoreae 20 grams, Fructus Corni 20 grams, Radix Adenophorae (Radix Glehniae) 20 grams, Bulbus Lilii 20 grams, Radix Ophiopogonis 20 grams, Cortex Moutan 15 grams, 15 grams, Poria, the Rhizoma Anemarrhenae 15 grams, Fructus Schisandrae Chinensis 12 grams, Cortex Phellodendri 12 grams, 12 grams, Colla Corii Asini, Rhizoma Alismatis 10 grams.
CN201410733093.9A 2014-12-07 2014-12-07 Traditional Chinese medicine composition for treating hemoptysis Pending CN104383256A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410733093.9A CN104383256A (en) 2014-12-07 2014-12-07 Traditional Chinese medicine composition for treating hemoptysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410733093.9A CN104383256A (en) 2014-12-07 2014-12-07 Traditional Chinese medicine composition for treating hemoptysis

Publications (1)

Publication Number Publication Date
CN104383256A true CN104383256A (en) 2015-03-04

Family

ID=52601280

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410733093.9A Pending CN104383256A (en) 2014-12-07 2014-12-07 Traditional Chinese medicine composition for treating hemoptysis

Country Status (1)

Country Link
CN (1) CN104383256A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104740380A (en) * 2015-03-06 2015-07-01 姜新帅 Traditional Chinese medicine composition for treating hemoptysis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陈国华: ""八仙长寿汤治咳血治案一则"", 《HTTP://HEALTH.GEGEN.NET.CN/2360.HTML》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104740380A (en) * 2015-03-06 2015-07-01 姜新帅 Traditional Chinese medicine composition for treating hemoptysis

Similar Documents

Publication Publication Date Title
CN104491142A (en) Traditional Chinese medicine composition for treating postnatal insomnia
CN102697868A (en) Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis
CN104383256A (en) Traditional Chinese medicine composition for treating hemoptysis
CN103800643A (en) Traditional Chinese medicine formula for treating goiter
CN103372083A (en) Chinese medicinal composition for treating spontaneous perspiration
CN103566322A (en) Medicine for treating chronic diarrhea
CN104398915A (en) Traditional Chinese medicinal composition for chronic eczema
CN103961652A (en) Traditional Chinese medicine composition for treating amenorrhea
CN104491305A (en) Traditional Chinese medicine composition for treating anxiety neurasthenia
CN104491780A (en) Traditional Chinese medicine composition for treating peripheral polyneuritis
CN104383241A (en) Traditional Chinese medicine composition for treating chronic pharyngitis
CN103386092A (en) Drug for treating infantile ascariasis
CN103505616A (en) Chinese medicinal composition for treating polycythemia vera
CN104383368A (en) Traditional Chinese medicine composition for treating bronchiectasia
CN106619914A (en) Dysentery treating traditional Chinese medicine formula
CN104491781A (en) Traditional Chinese medicine composition for treating colitis
CN105267790A (en) Breast sore medicinal pill for treating breast carcinoma
CN103800850A (en) Traditional Chinese medicine formula for treating goiter
CN105213878A (en) Control the tonification toxic removing prescription of breast carcinoma
CN104367800A (en) Traditional Chinese medicine composition for treating agranulocytosis
CN104383456A (en) Traditional Chinese medicine composition for treating costal chondritis
CN104306904A (en) Traditional Chinese medicine composite for treating fatty liver
CN104161792A (en) Traditional Chinese medicine composition for treating fungal enteritis
CN105213502A (en) A kind of combination of Chinese medicine for the treatment of galacturia
CN104367768A (en) Traditional Chinese medicine composition for treating polycythemia vera

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150304